Blood Pressure and Heart Rate Assessment in HOCM
Yes, a blood pressure of 116/80 mmHg with a heart rate of 55 bpm can be normal for a 57-year-old male with HOCM, particularly if he is on beta-blocker therapy, which is the recommended first-line treatment for this condition.
Understanding the Clinical Context
Beta-Blocker Therapy and Expected Vital Signs
The 2011 ACCF/AHA guidelines explicitly recommend titrating beta-blockers to achieve a resting heart rate of less than 60-65 bpm in symptomatic HOCM patients 1, 2, 1. This therapeutic target means:
- Heart rate of 55 bpm is within the desired therapeutic range if the patient is on beta-blocker therapy
- The blood pressure of 116/80 mmHg represents normotension, which is appropriate and safe in HOCM
Critical Safety Considerations
However, you must exercise caution with systemic hypotension in HOCM patients. The guidelines specifically warn that:
- Verapamil is potentially harmful in patients with obstructive HCM in the setting of systemic hypotension 1
- Pure vasodilators and high-dose diuretics are potentially harmful in patients with resting or provocable outflow tract obstruction 1
The blood pressure of 116/80 mmHg is not hypotensive—it's normotensive and appropriate.
When These Vital Signs Become Concerning
Red Flags Requiring Immediate Attention:
- If the patient is symptomatic (lightheadedness, syncope, severe dyspnea at rest)
- If systolic BP drops below 90-100 mmHg (systemic hypotension)
- If severe bradycardia develops (HR <50 bpm with symptoms or conduction disease)
- If these vital signs occur in the absence of beta-blocker therapy (may indicate autonomic dysfunction or severe obstruction)
Autonomic Dysfunction Context
Approximately 25% of HOCM patients demonstrate abnormal blood pressure responses during exercise, including hypotensive responses 3. This autonomic dysfunction can manifest as:
- Failure to augment systolic BP during exercise
- Sudden drops in BP during activity
- Association with poorer prognosis 4, 5
However, resting normotension with appropriate bradycardia on beta-blockers is distinctly different from pathologic hypotensive responses.
Management Algorithm
If Patient is on Beta-Blockers:
- Continue current therapy if asymptomatic
- Monitor for symptoms of hypoperfusion
- Ensure adequate hydration
- Avoid vasodilators, diuretics, and alcohol
If Patient is NOT on Beta-Blockers:
- Investigate the cause of bradycardia (conduction disease, sick sinus syndrome)
- Consider whether beta-blocker therapy should be initiated for symptom control
- Use caution if sinus bradycardia or severe conduction disease present 1, 2
If Patient Develops Hypotension (SBP <90 mmHg):
- Avoid inotropes (dopamine, dobutamine, norepinephrine are potentially harmful) 1
- Administer IV phenylephrine (pure vasoconstrictor) if unresponsive to fluids 1, 2, 1
- Ensure adequate preload with IV fluids
Common Pitfalls to Avoid
Do not discontinue beta-blockers solely based on HR of 55 bpm if the patient is asymptomatic—this is the therapeutic target 1, 2
Do not use vasodilating beta-blockers (carvedilol, labetalol) as they may worsen obstruction 6
Do not treat "low-normal" blood pressure with vasodilators or reduce beta-blocker dose unnecessarily—this can worsen LVOT obstruction
Do not assume bradycardia is always benign—assess for symptoms and conduction abnormalities
Educate patients about avoiding sudden position changes, dehydration, hot environments, and vasodilators (including sildenafil, nitrates) 6
Bottom Line
These vital signs are appropriate and expected in a HOCM patient on guideline-directed beta-blocker therapy. The key is ensuring the patient is asymptomatic and that these values represent therapeutic effect rather than pathologic hypotension or conduction disease. If symptomatic or if these values occur without beta-blocker therapy, further evaluation is warranted.